Copyright
©The Author(s) 2020.
World J Hepatol. Jun 27, 2020; 12(6): 312-322
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.312
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.312
General characteristics | |||
Median age (yr) | 37 ± 11.8 | (26–67) | n = 24 |
Gender: Male | 14 | (58) | n = 24 |
Median BMI (kg/m2) | 24 ± 4.5 | (18.9–34) | n = 24 |
Pregnancy at diagnosis | 0 | (0) | n = 10 |
Ethnicity | n = 24 | ||
Caucasian | 12 | (50) | |
Maghrebian | 10 | (42) | |
Asian | 1 | (4) | |
Sub-Saharan African | 1 | (4) | |
Medical history | |||
Acute pancreatitis | 13 | (54) | n = 24 |
Cholecystectomy | 10 | (42) | n = 24 |
Family history of cholelithiasis in first-degree relatives | 7 | (30) | n = 23 |
Acute cholecystitis | 3 | (13) | n = 24 |
Acute cholangitis | 3 | (13) | n = 24 |
Chronic pancreatitis | 0 | (0) | n = 24 |
Cholestasis of pregnancy | 0 | (0) | n = 10 |
Estrogen therapy | 0 | (0) | n = 10 |
Existing medical conditions | |||
Recurring pain | 21 | (88) | n = 24 |
Acute pancreatitis | 9 | (38) | n = 24 |
Acute cholecystitis | 2 | (14) | n = 14 |
Acute cholangitis | 1 | (4) | n = 24 |
Cytolysis | n = 23 | ||
Presence | 13 | (57) | |
Quantification (N) | 2.8 ± 3.1 | (0–10) | |
Cholestasis | n = 23 | ||
Presence | 13 | (57) | |
Quantification (N) | 1.7 ± 2.0 | (0–8) |
Intrahepatic bile duct findings | n = 24 | ||
Comet-tail artifacts | 23 | (96) | |
Microlithiasis | 20 | (83) | |
Acoustic shadows | 17 | (71) | |
Stones | 3 | (13) | |
Associated findings | |||
Gallstones | 6 | (43) | n = 14 |
Gallbladder sludge | 2 | (14) | n = 14 |
Gallbladder hydrops | 1 | (7) | n = 14 |
Common bile duct stones | 1 | (4) | n = 23 |
Follow-up time (mo) | 19.7 ± 5.8 | (10.1–29.4) | n = 24 |
Patients’ care | |||
Hospitalization | |||
In a conventional care unit | |||
Yes | 18 | (75) | n = 24 |
Duration (days) | 6.8 ± 3.1 | (2–14) | n = 18 |
In an intensive care unit | 0 | (0) | n = 24 |
Treatment | |||
UDCA | 18 | (75) | n = 24 |
Cholecystectomy | 5 | (36) | n = 14 |
Outcome | |||
Good adherence to UDCA | 12 | (67) | n = 18 |
UDCA efficacy | 17 | (94) | n = 18 |
Onset of action (in weeks) | 3.4 ± 2.5 | (2–12) | n = 17 |
Pain recurrence | 5 | (28) | n = 18 |
UDCA intolerance | 2 | (11) | n = 18 |
Death | 0 | (0) | n = 24 |
- Citation: Gille N, Karila-Cohen P, Goujon G, Konstantinou D, Rekik S, Bécheur H, Pelletier AL. Low phospholipid-associated cholelithiasis syndrome: A rare cause of acute pancreatitis that should not be neglected. World J Hepatol 2020; 12(6): 312-322
- URL: https://www.wjgnet.com/1948-5182/full/v12/i6/312.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i6.312